Abstract: The invention relates to the pharmaceutical composition for the treatment of a brain tumor, which contains in an effective amount from pharmaceutical point of view Peptidtoxin from spiders, Sicarius species and/or the saliva of the vipers from the Elaphe species; and the total poison or part of the spiders poison from the Latrodectus species, as well as the use of the pharmaceutical composition for the treatment of the brain tumor, a process for producing the pharmaceutical composition as well as a kit of parts containing the pharmaceutical composition.

Abstract: The invention relates to the pharmaceutical composition for the treatment of a brain tumor, which contains in an effective amount from pharmaceutical point of view Peptidtoxin from spiders, Sicarius species and/or the saliva of the vipers from the Elaphe species; and the total poison or part of the spiders poison from the Latrodectus species, as well as the use of the pharmaceutical composition for the treatment of the brain tumor, a process for producing the pharmaceutical composition as well as a kit of parts containing the pharmaceutical composition.

Abstract: Pharmaceutical active substance for treating tumors in the area of breast tissue (breast carcinoma) while using peptide toxin, a substance that acts in an antagonistic manner thereto, and/or a penetrating substance extracted from the venom of spiders of the family Lycosa tarantula.

Abstract: The present invention describes pharmaceutically effective substances from the poison of spiders of the family of Sicariidae as well as their preparation and their use in medicine.

Abstract: The invention describes dendritic cells loaded with toxic substances wherein the toxic substances are selected from the poison of scolopenders of the genera Scolopendra and Hemiscolopendra, snakes of the genera Bitis and Naja, spiders of the genera Loxosceles, Sicarius and Pholcus and Dysdera as well as scorpions of the genus Parabuthus and a combination of one or more of these toxins.

Abstract: The present invention describes a method for the preparation of dendritic cells wherein spinal cord stem cells grow in a nutrient medium in the presence of the growth factors GM-CSF and IL-4 and optionally in addition in the presence of the interleukin receptor sIL-4R until dendritic cells have formed. The thus prepared dendritic cells are preferably loaded with toxins, cytokins and/or cytokin receptors and are used in the treatment of tumor patients.

Abstract: The present invention describes pharmaceutically effective substances from the poison of spiders of the family of Sicariidae as well as their preparation and their use in medicine.